يعرض 1 - 20 نتائج من 26 نتيجة بحث عن '"80 and over Antibodies"', وقت الاستعلام: 0.56s تنقيح النتائج
  1. 1

    المصدر: Cytopathology. 30:460-467

  2. 2

    المصدر: Cancer Investigation. 32:144-149

    مصطلحات موضوعية: Male, Oncology, Cancer Research, Indoles, Skin Neoplasms, Time Factors, Molecular biology, Kaplan-Meier Estimate, Pharmacology, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Oximes, 80 and over, Cutaneous melanoma, Molecular biology, Treatment, Tumor immunology, Molecular Targeted Therapy, administration /&/ dosage, Vemurafenib, Melanoma, Aged, 80 and over, Sulfonamides, Imidazoles, Antibodies, Monoclonal, General Medicine, Middle Aged, adverse effects/therapeutic use, Treatment Outcome, Italy, drug therapy/enzymology/genetics/mortality/pathology, Cohort, Disease Progression, Tumor immunology, Female, Cutaneous melanoma, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, drug therapy/enzymology/genetics/mortality/secondary, Ipilimumab, Antibodies, Drug Administration Schedule, antagonists /&/ inhibitors/genetics/metabolism, Young Adult, Internal medicine, medicine, Humans, Protein Kinase Inhibitors, neoplasms, Aged, Retrospective Studies, business.industry, Adult, Aged, Aged, 80 and over, Antibodies, administration /&/ dosage, Antineoplastic Combined Chemotherapy Protocols, adverse effects/therapeutic use, Disease Progression, Drug Administration Schedule, Female, Humans, Imidazoles, administration /&/ dosage, Indoles, administration /&/ dosage, Italy, Kaplan-Meier Estimate, Male, Melanoma, drug therapy/enzymology/genetics/mortality/secondary, Middle Aged, Molecular Targeted Therapy, Mutation, Oximes, administration /&/ dosage, Protein Kinase Inhibitors, administration /&/ dosage, Proto-Oncogene Proteins B-raf, antagonists /&/ inhibitors/genetics/metabolism, Retrospective Studies, Skin Neoplasms, drug therapy/enzymology/genetics/mortality/pathology, Sulfonamides, administration /&/ dosage, Time Factors, Treatment Outcome, Young Adult, Dabrafenib, medicine.disease, digestive system diseases, Treatment, Expanded access, Mutation, business

  3. 3

    المصدر: Cardiology Journal. 20:310-317

    مصطلحات موضوعية: Male, Time Factors, Abciximab, medicine.medical_treatment, Rome, Left, Myocardial Infarction, Ventricular Function, Left, Settore MED/11, Bolus (medicine), Diastole, Monoclonal, 80 and over, Ventricular Function, Diastolic function, Myocardial infarction, Infusions, Intravenous, administration /&/ dosage, antagonists /&/ inhibitors, Aged, 80 and over, Ejection fraction, Antibodies, Monoclonal, General Medicine, Middle Aged, Coronary Vessels, Treatment Outcome, Injections, Intra-Arterial, Injections, Intravenous, Cardiology, Female, Intravenous, Cardiology and Cardiovascular Medicine, Perfusion, Adult, Infusions, medicine.medical_specialty, Adult, Aged, Aged, 80 and over, Antibodies, administration /&/ dosage, Coronary Vessels, Diastole, drug effects, Female, Humans, Immunoglobulin Fab Fragments, administration /&/ dosage, Infusions, Intravenous, Injections, Intra-Arterial, Injections, Intravenous, Male, Middle Aged, Myocardial Infarction, diagnosis/physiopathology/therapy, Peptides, administration /&/ dosage, Percutaneous Coronary Intervention, adverse effects, Platelet Aggregation Inhibitors, administration /&/ dosage, Platelet Glycoprotein GPIIb-IIIa Complex, antagonists /&/ inhibitors, Recovery of Function, Rome, Systole, drug effects, Time Factors, Treatment Outcome, Ventricular Function, drug effects, Systole, Eptifibatide, Platelet Glycoprotein GPIIb-IIIa Complex, Antibodies, Injections, Immunoglobulin Fab Fragments, Percutaneous Coronary Intervention, Internal medicine, medicine, Humans, diagnosis/physiopathology/therapy, Aged, Intra-Arterial, business.industry, Percutaneous coronary intervention, Recovery of Function, medicine.disease, Conventional PCI, adverse effects, Peptides, Glycoprotein IIb/IIIa, business, Platelet Aggregation Inhibitors

  4. 4

    المصدر: British Journal of Haematology. 154:271-274

  5. 5
    Academic Journal
  6. 6

    المصدر: Journal of Experimental & Clinical Cancer Research : CR

  7. 7

    المصدر: British Journal of Cancer

  8. 8

    المصدر: Cancer immunology, immunotherapy : CII. 63(7)

  9. 9
  10. 10

    المساهمون: M., Scartozzi, R., Giampieri, E., Maccaroni, A., Mandolesi, S., Biagetti, S., Alfonsi, L., Giustini, C., Loretelli, L., Faloppi, A., Bittoni, M., Bianconi, M. D., Prete, I., Bearzi, Cascinu, Stefano

    المصدر: Journal of Translational Medicine
    Journal of Translational Medicine, Vol 10, Iss 1, p 71 (2012)

    مصطلحات موضوعية: Oncology, MAPK/ERK pathway, Male, Cancer Research, Colorectal cancer, Antibodie, medicine.medical_treatment, lcsh:Medicine, Cetuximab, Colorectal Neoplasm, Mitogen-Activated Protein Kinase, Phosphorylated akt, Liver metastases, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Neoplasm Metastasis, Phosphorylation, administration /&/ dosage, Medicine(all), Aged, 80 and over, Kinase, Phosphorylated AKT, Antibodies, Monoclonal, General Medicine, Middle Aged, Immunohistochemistry, Neoplasm Metastasi, Treatment Outcome, Adult, Aged, Aged, 80 and over, Antibodies, administration /&/ dosage, Antineoplastic Combined Chemotherapy Protocols, therapeutic use, Camptothecin, administration /&/ dosage/analogs /&/ derivatives, Colorectal Neoplasms, drug therapy/enzymology/pathology, Female, Humans, Immunohistochemistry, Male, Middle Aged, Mitogen-Activated Protein Kinases, metabolism, Neoplasm Metastasis, Phosphorylation, Proto-Oncogene Proteins c-akt, metabolism, Treatment Outcome, Female, Mitogen-Activated Protein Kinases, Colorectal Neoplasms, K-RAS, dosage/analogs /&, Human, medicine.drug, Adult, medicine.medical_specialty, Antibodies, Monoclonal, Humanized, Irinotecan, Antibodies, General Biochemistry, Genetics and Molecular Biology, Internal medicine, administration /&/ dosage/analogs /&/ derivatives, dosage, medicine, Humans, Egfr signaling, Protein kinase B, Aged, Chemotherapy, Antineoplastic Combined Chemotherapy Protocol, Biochemistry, Genetics and Molecular Biology(all), business.industry, Research, lcsh:R, drug therapy/enzymology/pathology, medicine.disease, derivative, therapeutic use, Potential biomarkers, Phosphorylated MAPK, administration /&, Cancer research, Camptothecin, business, metabolism, Proto-Oncogene Proteins c-akt

  11. 11
  12. 12

    المصدر: Journal of immunology (Baltimore, Md. : 1950). 186(10)

    مصطلحات موضوعية: Male, Lymphoma, medicine.disease_cause, Antibodies, Viral, immunology/prevention /&/ control, Antibodies, Monoclonal, Murine-Derived, Influenza A Virus, H1N1 Subtype, analogs /&/ derivatives/therapeutic use, immune system diseases, hemic and lymphatic diseases, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Influenza A Virus, Influenza A virus, Immunology and Allergy, Viral, Aged, 80 and over, B-Lymphocytes, Lymphoma, Non-Hodgkin, Adult, Aged, Aged, 80 and over, Antibodies, Murine-Derived, immunology/therapeutic use, Antibodies, blood, Antigens, CD27, immunology, Antineoplastic Combined Chemotherapy Protocols, therapeutic use, B-Lymphocytes, immunology, Case-Control Studies, Female, Humans, Immunoglobulin M, blood, Immunologic Memory, Influenza A Virus, H1N1 Subtype, immunology, Influenza A Virus, H3N2 Subtype, immunology, Influenza B virus, immunology, Influenza Vaccines, administration /&/ dosage/immunology, Influenza, Human, immunology/prevention /&/ control, Lymphoma, Non-Hodgkin, drug therapy/immunology, Male, Middle Aged, Orthomyxoviridae, immunology, Vidarabine, Middle Aged, Orthomyxoviridae, Fludarabine, Vaccination, medicine.anatomical_structure, Influenza Vaccines, immunology/therapeutic use, Rituximab, Female, Vidarabine, medicine.drug, Adult, Influenza vaccine, Immunology, drug therapy/immunology, Antibodies, Article, blood, administration /&/ dosage/immunology, Influenza, Human, medicine, Humans, Antigens, B cell, Aged, business.industry, Influenza A Virus, H3N2 Subtype, medicine.disease, Influenza, Non-Hodgkin's lymphoma, Tumor Necrosis Factor Receptor Superfamily, Member 7, Influenza B virus, Immunoglobulin M, therapeutic use, Case-Control Studies, business, Immunologic Memory

  13. 13

    المساهمون: Mount Vernon Cancer Centre, Mount Breast Group, Mount Hospital, Algemeen Ziekenhuis St Augustinus Oncology, Joan Albanell, Hospital del Mar, Vall d'Hebron University Hospital [Barcelona], Service d'Oncologie Médicale [CHRU Besançon], Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Interactions hôte-greffon-tumeur, ingénierie cellulaire et génique - UFC (UMR INSERM 1098) (RIGHT), Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS [Bourgogne-Franche-Comté])-Université de Franche-Comté (UFC), Klinika Onkologii Oddzial Chemioterapii, Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Yonsei Uni College of Medicine, Centre des Maladies du Sein Deschênes-Fabia, Università degli Studi di Udine - University of Udine [Italie], Frauenklinik, Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM), Medizinische Universität Wien = Medical University of Vienna, Universität Heidelberg [Heidelberg], Cancer research, The Christie, Pharmaceutical Division, F. Hoffmann-La Roche [Basel], CRLC Val d'Aurelle-Paul Lamarque, CRLCC Val d'Aurelle - Paul Lamarque, Saas, Philippe, UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)

    المصدر: Journal of Clinical Oncology
    Journal of Clinical Oncology, American Society of Clinical Oncology, 2010, 28 (20), pp.3239-47. ⟨10.1200/JCO.2008.21.6457⟩

    مصطلحات موضوعية: Cancer Research, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antibodies, administration /&/ dosage, Antineoplastic Combined Chemotherapy Protocols, adverse effects/therapeutic use, Breast Neoplasms, drug therapy/metabolism/pathology, Drug Administration Schedule, Female, Humans, Middle Aged, Neoplasm Metastasis, Neoplasm Recurrence, Local, drug therapy, Placebos, administration /&/ dosage, Receptor, Epidermal Growth Factor, metabolism, Taxoids, administration /&/ dosage, MESH: Taxoids, Docetaxel, MESH: Antibodies, Monoclonal, Placebos, 0302 clinical medicine, MESH: Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Neoplasm Metastasis, Humanized, drug therapy/metabolism/pathology, Aged, 80 and over, MESH: Aged, 0303 health sciences, MESH: Middle Aged, Hazard ratio, Antibodies, Monoclonal, Middle Aged, Metastatic breast cancer, 3. Good health, drug therapy, Bevacizumab, ErbB Receptors, adverse effects/therapeutic use, MESH: Antineoplastic Combined Chemotherapy Protocols, Oncology, 030220 oncology & carcinogenesis, Female, Taxoids, Breast disease, MESH: Neoplasm Recurrence, Local, medicine.drug, Receptor, Adult, medicine.medical_specialty, Urology, MESH: Placebos, Breast Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, MESH: Receptor, Epidermal Growth Factor, MESH: Drug Administration Schedule, Placebo, Antibodies, Monoclonal, Humanized, Antibodies, Drug Administration Schedule, 03 medical and health sciences, Breast cancer, [SDV.CAN] Life Sciences [q-bio]/Cancer, medicine, Humans, 030304 developmental biology, Aged, MESH: Humans, business.industry, Cancer, MESH: Adult, medicine.disease, MESH: Neoplasm Metastasis, Surgery, Neoplasm Recurrence, Neoplasm Recurrence, Local, business, metabolism, MESH: Female, MESH: Breast Neoplasms

  14. 14

    المساهمون: Infectious and Tropical Diseases, Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome], Gastroenterology, Università degli studi di Palermo - University of Palermo, Public,Clinical and Preventive Medicine, University of Naples Federico II, Laboratory of Epidemiology, Clinical Epidemiology Unit, Istituto Superiore di Sanita [Rome], Infectious Diseases Dept, Stroffolini T., Almasio P.L., Sagnelli E., Mele A., Gaeta G.B., Italian Hospitals' Collaborating Group, Andreone P., Scuteri A., Antonucci G., Iacomi F., Babudieri S., Pintus A., Stornaiuolo G., Brancaccio G., Brunetto M., Sasso R., Caporaso N., Morisco F., Chiaramonte M., Lattanzi E., Di Marco V., Venezia G., Fagiuoli S., Boninsegna S., Fattovich G., Olivari N., Ferrari C., Giuberti T., Ferrigno L., Magnani G., Massari M., Mangano C., Caserta C., Messina V., Pastore G., Palattella S., Piccinino F., Stanzione M., Pinzello G., Vinci M., Raimondo G., Caccamo G., Roffi L., Bellia V., Rizzetto M., Smedile A., Ciancio A., Stroffolini, T, Almasio, P, Sagnelli, E, Mele, A, Gaeta, G, Andreone, P, Scuteri, A, Antonucci, G, Iacomi, F, Babudieri, S, Pintus, A, Stornaiuolo, G, Brancaccio, G, Brunetto, M, Sasso, R, Caporaso, N, Morisco, F, Chiaramonte, M, Lattanzi, E, Di Marco, V, Venezia, G, Fagiuoli, S, Boninsegna, S, Fattovich, G, Olivari, N, Ferrari, C, Giuberti, T, Ferrigno, L, Magnani, G, Massari, M, Mangano, C, Caserta, C, Messina, V, Pastore, G, Palattella, S, Piccinino, F, Stanzione, M, Pinzello, G, Vinci, M, Raimondo, G, Caccamo, G, Roffi, L, Bellia, V, Rizzetto, M, Smedile, A, Ciancio, A

    المصدر: Journal of Medical Virology
    Journal of Medical Virology, Wiley-Blackwell, 2009, 81 (12), pp.1999. ⟨10.1002/jmv.21643⟩

    وصف الملف: STAMPA

  15. 15
  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20
    Academic Journal